Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale

NCT06278532 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.

NCT NCT06278532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06278532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale
Lead sponsor
Lithuanian University of Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
December 11, 2023
Completion date
December 11, 2026
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficit, depressive symptoms due to primary psychotic disorder (diagnosis), negative symptoms in schizophrenia, schizophrenia